HIV/AIDS

Funding

• Phased Innovation Awards (PIA) fund exploratory projects to bring new concepts into the research and development "pipeline."

• HIV Vaccine Research and Design (HIVRAD) program advances concepts further towards the development of a prophylactic AIDS vaccine.
• Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) supports the later stages of preventive HIV/AIDS vaccine concept refinement and testing, culminating in human studies.
• HIV Vaccine Design and Development Teams (HVDDT) fund consortia of scientists with development experience from industry and/or academia that have identified a promising vaccine concept and envisioned a product worthy of targeted development.
• Highly Innovative Tactics to Interrupt Transmission of HIV (HIT-IT) is a forthcoming potential funding opportunity cleared at NIAID Council in January 2008 to stimulate research on novel, unconventional, outside-the-box, high-risk, and/or potential high-impact approaches that may provide long-term, safe protection from HIV infection.